Satsuma Pharmaceuticals, Inc. - 80405P107

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2023 · Q4 2022
Value (USD)
Total reported value ($000)
$5.971M
QoQ value delta ($000)
-$2.9M (-32.69%)
Implied price effect (QoQ)
-22.39%
Shares
Total shares
8,557,998
QoQ shares delta
-1,309,987 (-13.28%)
Total shares held by funds (by quarter)

Top holders (Q1 2023)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
RA CAPITAL MANAGEMENT, L.P. 4,131 5,914,252 0.09%
VANGUARD GROUP INC 642 920,517 0.0%
GEODE CAPITAL MANAGEMENT, LLC 289 414,344 0.0%
TWO SIGMA INVESTMENTS, LP 207 297,129 0.0%
TWO SIGMA ADVISERS, LP 191 274,000 0.0%
RENAISSANCE TECHNOLOGIES LLC 115 164,500 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84 120,300 0.0%
CITADEL ADVISORS LLC 80 114,597 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 68 98,000 0.0%
STATE STREET CORP 43 62,236 0.0%
NORTHERN TRUST CORP 29 42,193 0.0%
BANK OF AMERICA CORP /DE/ 25 36,592 0.0%
SIMPLEX TRADING, LLC 15 21,864 0.0%
BARCLAYS PLC 11 15,841 0.0%
ADVISOR GROUP HOLDINGS, INC. 11 16,000 0.0%
BLAIR WILLIAM & CO/IL 10 15,000 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 8 11,968 0.0%
Tower Research Capital LLC (TRC) 6 8,280 0.0%
MORGAN STANLEY 5 7,932 0.0%
UBS Group AG 1 1,815 0.0%
WELLS FARGO & COMPANY/MN 0 185 0.0%
CITIGROUP INC 0 8 0.0%
GROUP ONE TRADING, L.P. 0 445 0.0%